Histocell
PrivateLast Round
Corporate Funding
Dec 12, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Histocell operates in Healthcare & Life Sciences and is based in Derio. Its latest recorded funding round was a Corporate Funding round in December 2022.
Histocell is a biotechnology company that develops and manufactures cell therapy products, biological medicinal products, and innovative medical devices for regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Histocell Comparables
Compare Histocell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stemmatters, Biotecnologia e Medicina Regenerativa S.A. | 91% | |
| Cell-Easy | 86% | |
| eXmoor Pharma | 84% |
For institutional investors. Book with your work email.
Histocell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 12, 2022 | ||||
| Corporate Funding | Nov 24, 2022 | ||||
| VC Round | Sep 14, 2018 | ||||
| VC Round | Sep 30, 2016 | ||||
| VC Round | Apr 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Histocell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seed Capital Bizkaia | VC Round |
| Gestión de Capital Riesgo del País Vasco - Grupo SPRI | VC Round |
| Orza | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM.
- Jul 25, 2026
Monthly visitors grew 202% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Histocell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Histocell's valuation, stock price, and market status.
Is Histocell a public or private company?
Histocell is a private company.
What is the current stock price of Histocell?
Histocell is a private company, so its shares have no public market price. Caplight tracks Histocell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Histocell worth (valuation)?
Valuation information for Histocell is not publicly available.
Can I buy Histocell stock?
Histocell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Histocell's last funding round?
Histocell's most recent funding round was Corporate Funding on December 12, 2022.
Who are the main investors in Histocell?
Key investors in Histocell include Seed Capital Bizkaia, Gestión de Capital Riesgo del País Vasco - Grupo SPRI, Orza.
Will Histocell IPO soon?
No public IPO plans have been announced for Histocell.
How can I track Histocell secondary market activity?
Caplight tracks bids, offers, and trades in Histocell's shares on secondary markets.